| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/20/2008 | CN100411678C Chinese medicine bone-setting ointment and preparing method |
| 08/20/2008 | CN100411677C Pharmaceutical composition and its preparing method and usage |
| 08/20/2008 | CN100411673C Medicine for treating arthritis and its preparation |
| 08/20/2008 | CN100411672C A medicinal composition for treatment of psoriasis |
| 08/20/2008 | CN100411671C Chinese medicinal composition for relieving sports fatigue and improving performance and method for preparing same |
| 08/20/2008 | CN100411669C Chinese medicine for treating chronic virus hepatitis B and its producing method |
| 08/20/2008 | CN100411667C Immune balancing energy restoring ointment and its manufacturing method |
| 08/20/2008 | CN100411666C Broad-specturm medicine for treating snake venom poisoning |
| 08/20/2008 | CN100411665C An externally applied Chinese medicinal bag for relieving pain |
| 08/20/2008 | CN100411664C Preparation method of medicine for treating nasopharynx inflam mation |
| 08/20/2008 | CN100411662C Colpitis medicine and its preparation |
| 08/20/2008 | CN100411661C Amber bolus |
| 08/20/2008 | CN100411660C Chinese medicine composition for treating optic atrophy and preparing method therefor |
| 08/20/2008 | CN100411657C Green biota body cleaning effervescent particle preparation |
| 08/20/2008 | CN100411651C Medical gel and its preparing method and device |
| 08/20/2008 | CN100411650C A compound capsule for treating Bi syndrome |
| 08/20/2008 | CN100411646C Application of pharmaceutical composition in the process for preparing medicine to counteract aspirin resisting medicine |
| 08/20/2008 | CN100411641C Use of dripping pill in preparing medicine for treating anti-aspirin |
| 08/20/2008 | CN100411639C Use of compound red-rooted salvia drop pills in preparation of albumin leakage prohibiting drug |
| 08/20/2008 | CN100411636C Ointment of burns and scalds for acesodyne within 30 minutes, and preparation method |
| 08/20/2008 | CN100411635C Troche of health products, preparation and application thereof |
| 08/20/2008 | CN100411631C Orally administered compound antihyperlipidemic |
| 08/20/2008 | CN100411627C Desensitization face pack for treating facial dermatitis |
| 08/20/2008 | CN100411624C Aqueous compositions containing metronidazole |
| 08/20/2008 | CN100411621C Cefixime oral disintegration tablet and its preparation method |
| 08/20/2008 | CN100411616C Methocarbamol dispersion tablet |
| 08/20/2008 | CN100411615C Effect of aminoguanidine for curing wound surface in refractory to treatment |
| 08/20/2008 | CN100411614C Production of tremella-polysaccharose capsules |
| 08/20/2008 | CN100411613C Fast releasing solid omeprazole prepn and its preparation process |
| 08/20/2008 | CN100411612C Quick-disintegration tablets of calcium atovastatine, and its preparation method |
| 08/20/2008 | CN100411611C Matrix for sustained, invariant and independent release of active compounds |
| 08/20/2008 | CN100411610C Liposome able to transmit blood and brain screen, medicinal compositions using hiposome as carrier and its preparation method |
| 08/20/2008 | CN100411609C Nano-emulsion drug of triperygium wilfordii polycoride and preparation method thereof |
| 08/20/2008 | CN100411608C Method of preparing a formulation containing a microdosed active component |
| 08/19/2008 | US7415306 Transdermal delivery system for anti-emetic medication |
| 08/19/2008 | US7415302 Method and system for leading macromolecule substances into living target cells |
| 08/19/2008 | US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping |
| 08/19/2008 | US7414044 peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethylsulfoxide; dye containing a chelated metal, such as hematoporphyrin; aromatic redox compound, such as benzoquinone |
| 08/19/2008 | US7414039 Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis |
| 08/19/2008 | US7414038 embolizing agent for arteriovenous aneurysm, which comprises the embolizing material and an appropriate physiologically acceptable water-soluble organic acid |
| 08/19/2008 | US7413781 Gels for encapsulation of biological materials |
| 08/19/2008 | US7413770 Ethylene glycol monolayer protected nanoparticles |
| 08/19/2008 | US7413753 Containing an effective amount of an effervescent agent. |
| 08/19/2008 | US7413752 Locally implantable and absorbable drug delivery capable of delivering relatively low molecular weight compounds in a sustained fashion |
| 08/19/2008 | US7413751 Methods of treatment using a gastric retained losartan dosage |
| 08/19/2008 | US7413750 Process for producing solid oral dosage forms with sustained release of active ingredient |
| 08/19/2008 | US7413749 Adimistering analgesics by titration for dosage using tramadol and kits |
| 08/19/2008 | US7413748 comprises patches for improved dosage |
| 08/19/2008 | US7413747 Transdermal therapeutic system for treating Parkinsonism |
| 08/19/2008 | US7413538 Epitopes formed by non-covalent association of conjugates |
| 08/19/2008 | CA2488422C Stable solid medicinal ramosetron composition for oral administration |
| 08/19/2008 | CA2468708C Formulations comprising a cephalosporin compound and their use treating bacterial infections in cats and dogs |
| 08/19/2008 | CA2421399C Dry-powder film coating composition and method of preparation |
| 08/19/2008 | CA2396722C Formulations of active components in the form of a solid dispersion |
| 08/19/2008 | CA2390886C Use of fumaric acid derivatives for treating mitochondrial diseases |
| 08/19/2008 | CA2370003C A composition and method for the enhancement of the efficacy of drugs |
| 08/19/2008 | CA2353943C Method of drying a lactulose solution |
| 08/19/2008 | CA2341732C Powder composition for nasal administration |
| 08/19/2008 | CA2282682C Tazarotene and corticosteroid treatment for psoriasis |
| 08/15/2008 | CA2578647A1 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 08/14/2008 | WO2008098192A2 Compositions and methods for treating neuropathy |
| 08/14/2008 | WO2008098180A2 Complementary personal lubrificant compositions and delivery system |
| 08/14/2008 | WO2008098019A2 Polymer formulations for delivery of bioactive agents |
| 08/14/2008 | WO2008097971A2 Methods for treating diseases of altered ige regulation |
| 08/14/2008 | WO2008097953A2 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 08/14/2008 | WO2008097897A2 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1(pai-1) |
| 08/14/2008 | WO2008097664A1 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
| 08/14/2008 | WO2008097539A2 Multi-modal absorption, medicine-delivery lozenge, and use thereof |
| 08/14/2008 | WO2008097530A1 Increased effectiveness of allylamine drug compounds |
| 08/14/2008 | WO2008097529A1 Tissue compatible material and methods using same |
| 08/14/2008 | WO2008097328A2 Asymmetric functionalized nanoparticles and methods of use |
| 08/14/2008 | WO2008097317A1 Solvating system and sealant for medical use |
| 08/14/2008 | WO2008097233A1 Stable pharmaceutical drug aerosols |
| 08/14/2008 | WO2008097220A1 Olopatadine formulations for topical nasal administration |
| 08/14/2008 | WO2008097165A1 Process for preparation of a stable dispersion of solid amorphous submicron particles in an aqueous medium |
| 08/14/2008 | WO2008097066A1 An oral sustained-release triple layer tablet |
| 08/14/2008 | WO2008096904A1 Mannose 6-phosphate-polyethylene glycol conjugate |
| 08/14/2008 | WO2008096888A1 Powder composition, method for producing the same, and food composition, cosmetic composition and pharmaceutical composition containing the same |
| 08/14/2008 | WO2008096804A1 Eye drop preparation comprising latanoprost |
| 08/14/2008 | WO2008096779A1 C70-containing liposome, method for producing the same, and use of the same |
| 08/14/2008 | WO2008096690A1 Polyethylene glycol derivative |
| 08/14/2008 | WO2008096547A1 Anti-tumor composition comprising tissue-accumulating chitosan gel |
| 08/14/2008 | WO2008096377A2 Stable atorvastatin formulations |
| 08/14/2008 | WO2008096351A1 Pharmaceutical compositions based on a microemulsion |
| 08/14/2008 | WO2008096321A1 Nanocapsules of lipophilic complexes of nucleic acids |
| 08/14/2008 | WO2008096237A2 Method for realising active ingredients in order to protect them and optimise their delivery mode |
| 08/14/2008 | WO2008096151A1 Pharmaceutical compositions of cb1 modulators |
| 08/14/2008 | WO2008096144A1 Method of creating crystalline substances |
| 08/14/2008 | WO2008095810A1 Packaged product combination |
| 08/14/2008 | WO2008095796A1 Dermatological emulsion and method for the preparation thereof |
| 08/14/2008 | WO2008095688A1 Free-flowing gelatin composition |
| 08/14/2008 | WO2008095652A1 Transport of drugs via the blood-brain barrier by means of apolipoproteins |
| 08/14/2008 | WO2008095597A2 Transdermal therapeutic system for administering water-soluble active ingredients |
| 08/14/2008 | WO2008095588A1 Composition comprising chitosan and an acidic drug for oral controlled release |
| 08/14/2008 | WO2008095479A2 Use of a highly emulsified silicone oil (hes) for the production of a medicament |
| 08/14/2008 | WO2008095307A1 Bioceramic implants having bioactive substance |
| 08/14/2008 | WO2008095284A1 Fast-disintegrating epinephrine tablets for buccal or sublingual administration |
| 08/14/2008 | WO2008095263A1 A dosage form containing two or more active pharmaceutical ingredients in different physical forms |
| 08/14/2008 | WO2008095256A1 Hollow microparticles |
| 08/14/2008 | WO2008079343A3 Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients |